NEPH - NEPHROS INC


1.87
0.060   3.209%

Share volume: 32,042
Last Updated: 04-09-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 0.17%

PREVIOUS CLOSE
CHG
CHG%

$1.81
0.06
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
23%
Profitability 0%
Dept financing 13%
Liquidity 63%
Performance 39%
Company vs Stock growth
vs
Performance
5 Days
-4.10%
1 Month
15.43%
3 Months
23.82%
6 Months
28.35%
1 Year
-11.79%
2 Year
34.05%
Key data
Stock price
$1.87
P/E Ratio 
209.46
DAY RANGE
$1.81 - $1.89
EPS 
$0.01
52 WEEK RANGE
$1.36 - $2.55
52 WEEK CHANGE
-$6.52
MARKET CAP 
15.500 M
YIELD 
N/A
SHARES OUTSTANDING 
10.544 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
0.57
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$23,600
AVERAGE 30 VOLUME 
$13,991
Company detail
CEO: Andrew Astor
Region: US
Website: nephros.com
Employees: 30
IPO year: 2006
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Nephros, Inc. develops and sells high performance water solutions to medical and commercial markets. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.

Recent news
loading